Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Ohta

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Surgical Endoscopy|February 3, 2022
Colonic stent as a bridge to surgery versus emergency resection for right-sided malignant large bowel obstruction: a meta-analysisShintaro Kanaka, Akihisa Matsuda, Takeshi Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Consideration for Prognostic Indicators of Ovarian Metastasis of Colorectal Cancer]Koji Ueda, Seiichi Shinji, Takeshi Yamada, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 22, 2019
Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastasesTakuma Iwai, Takeshi Yamada, Goro Takahashi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2021
Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancerHiromichi Sonoda, Takeshi Yamada, Akihisa Matsuda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2022
BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsyKoji Ueda, Takeshi Yamada, Ryo Ohta, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|October 26, 2014
Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acidsKohji Yamakage, Hajime Sui, Ryo Ohta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2021
Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancerRyo Ohta, Takeshi Yamada, Hiromichi Sonoda, et al.
International Journal of Clinical Oncology|August 14, 2020
Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in JapanRyo Ohta, Takeshi Yamada, Keisuke Hara, et al.
Cancer Science|August 30, 2019
Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cellsKohki Takeda, Takeshi Yamada, Goro Takahashi, et al.
Scientific Reports|November 3, 2016
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cellsRyo Ohta, Akira Niwa, Yukimasa Taniguchi, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Surgical Endoscopy|February 3, 2022
Colonic stent as a bridge to surgery versus emergency resection for right-sided malignant large bowel obstruction: a meta-analysisShintaro Kanaka, Akihisa Matsuda, Takeshi Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Consideration for Prognostic Indicators of Ovarian Metastasis of Colorectal Cancer]Koji Ueda, Seiichi Shinji, Takeshi Yamada, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 22, 2019
Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastasesTakuma Iwai, Takeshi Yamada, Goro Takahashi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2021
Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancerHiromichi Sonoda, Takeshi Yamada, Akihisa Matsuda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2022
BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsyKoji Ueda, Takeshi Yamada, Ryo Ohta, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|October 26, 2014
Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acidsKohji Yamakage, Hajime Sui, Ryo Ohta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 28, 2021
Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancerRyo Ohta, Takeshi Yamada, Hiromichi Sonoda, et al.
International Journal of Clinical Oncology|August 14, 2020
Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in JapanRyo Ohta, Takeshi Yamada, Keisuke Hara, et al.
Cancer Science|August 30, 2019
Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cellsKohki Takeda, Takeshi Yamada, Goro Takahashi, et al.
Scientific Reports|November 3, 2016
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cellsRyo Ohta, Akira Niwa, Yukimasa Taniguchi, et al.
Pageof 13